Document Detail


Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
MedLine Citation:
PMID:  21412885     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Concerns regarding the safety of transfused blood have generated considerable enthusiasm for the use of technologies intended to reduce the use of allogeneic blood (blood from an unrelated donor). Platelet-rich plasmapheresis (PRP) offers an alternative approach to blood conservation.
OBJECTIVES: To examine the evidence for the efficacy of PRP in reducing peri-operative allogeneic red blood cell (RBC) transfusion, and the evidence for any effect on clinical outcomes such as mortality and re-operation rates.
SEARCH STRATEGY: We identified studies by searching MEDLINE (1950 to 2009), EMBASE (1980 to 2009), The Cochrane Library (Issue 1, 2009), the Internet (to March 2009) and the reference lists of published articles, reports, and reviews.
SELECTION CRITERIA: Controlled parallel group trials in which adult patients, scheduled for non-urgent surgery, were randomised to PRP, or to a control group which did not receive the intervention.
DATA COLLECTION AND ANALYSIS: Primary outcomes measured were: the number of patients exposed to allogeneic RBC transfusion, and the amount of RBC transfused. Other outcomes measured were: the number of patients exposed to allogeneic platelet transfusions, fresh frozen plasma, and cryoprecipitate, blood loss, re-operation for bleeding, post-operative complications (thrombosis), mortality, and length of hospital stay. Treatment effects were pooled using a random-effects model. Trial quality was assessed using criteria proposed by Schulz et al (Schulz 1995).
MAIN RESULTS: Twenty-two trials of PRP were identified that reported data for the number of patients exposed to allogeneic RBC transfusion. These trials evaluated a total of 1589 patients. The relative risk (RR) of exposure to allogeneic blood transfusion in those patients randomised to PRP was 0.73 (95%CI 0.59 to 0.90), equating to a relative risk reduction (RRR) of 27% and a risk difference (RD) of 19% (95%CI 10% to 29%). However, significant heterogeneity of treatment effect was observed (p < 0.00001; I² = 79%). When the four trials by Boldt are excluded, the RR is 0.76 (95% CI 0.62 to 0.93). On average, PRP did not significantly reduce the total volume of RBC transfused (weighted mean difference [WMD] -0.69, 95%CI -1.93 to 0.56 units). Trials provided inadequate data regarding the impact of PRP on morbidity, mortality, and hospital length of stay. Trials were generally small and of poor methodological quality.
AUTHORS' CONCLUSIONS: Although the results suggest that PRP is effective in reducing allogeneic RBC transfusion in adult patients undergoing elective surgery, there was considerable heterogeneity of treatment effects and the trials were of poor methodological quality. The available studies provided inadequate data for firm conclusions to be drawn regarding the impact of PRP on clinically important endpoints.
Authors:
Paul A Carless; Fraser D Rubens; Danielle M Anthony; Dianne O'Connell; David A Henry
Related Documents :
20824625 - Evidence-based selection criteria to protect blood donors.
806175 - Selective iga deficiency in blood donors.
2048185 - Screening potential blood donors at risk for human immunodeficiency virus.
882845 - Time-related increase in leucocyte yields by continuous-flow centrifugation (cfc) leuko...
3535535 - Hormonal responses associated with early hyperglycemia after graded hemorrhage in dogs.
359015 - Methods for the assessment of the effects of drugs on coronary blood flow in man.
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2011-03-16
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2011  
Date Detail:
Created Date:  2011-03-17     Completed Date:  2011-04-01     Revised Date:  2014-09-24    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD004172     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Loss, Surgical / prevention & control
Humans
Plasmapheresis / methods*
Platelet Transfusion / utilization*
Randomized Controlled Trials as Topic
Surgical Procedures, Elective
Transplantation, Homologous
Comments/Corrections
Update Of:
Cochrane Database Syst Rev. 2003;(2):CD004172   [PMID:  12804502 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-immunosuppressive treatment for IgA nephropathy.
Next Document:  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.